Therma Bright Inc. (TBRIF) Research

Based in Toronto, Canada, Therma Bright Inc., established in 2001 and formerly known as The Jenex Corporation until its rebranding in 2018, specializes in the creation and commercialization of a diverse portfolio of medical and consumer health devices. Their offerings include rapid diagnostic tests for COVID-19, such as AcuVid, which screens for both antigens and antibodies. The company also provides innovative solutions for pain management and other health concerns, featuring InterceptCS, a system utilizing controlled topical heat to prevent cold sores, and Benepod, a hot and cold contrast therapy device designed for drug-free pain relief. Furthermore, they offer the Venowave medical compression pump to treat symptoms associated with poor circulation. For insect bites and stings, Therma Bright produces TherOZap, a thermal therapy device that effectively reduces inflammatory responses, itching, and pain. Their products cater to a broad market, serving both general consumers and healthcare professionals.

Open Therma Bright Inc. (TBRIF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.